Colorado Marijuana DUI (DUI-D) Defense

The 5 ng/mL Threshold Is a Permissive Inference, Not a Per Se Limit

Colorado's marijuana DUI statute is C.R.S. § 42-4-1301. The statute prohibits driving while under the influence of any drug, marijuana, or controlled substance. It also creates a permissive inference: if the driver's whole-blood delta-9 THC concentration is 5 ng/mL or higher at the time of testing, the jury may infer that the driver was under the influence. The jury is not required to draw the inference. The prosecution still has to prove actual impairment beyond a reasonable doubt.

That language matters. Colorado's alcohol DUI statute makes a BAC of 0.08 or higher a separate "DUI per se" offense — the test result itself is the violation. Colorado's marijuana DUI statute does not. A driver with a blood THC concentration of 8 ng/mL who was not actually impaired has a defense; a driver with a BAC of 0.10 has the per se charge to overcome. The legal difference is a substantive defense difference.

The reason the Colorado legislature chose a permissive-inference framework for THC, while sticking with per se for alcohol, is that the underlying science is different. Delta-9 THC pharmacokinetics — particularly for chronic users — produce blood concentrations that do not correlate cleanly with impairment in the way BAC does. Recognizing this, the legislature built in the jury's discretion. A good defense uses that discretion.

Why Chronic Users Test Above 5 ng/mL Without Impairment

The pharmacology of delta-9 THC has been the subject of substantial peer-reviewed research, including studies sponsored by AAA Foundation for Traffic Safety, the National Highway Traffic Safety Administration, and the Colorado Department of Public Safety. The consistent finding: delta-9 THC blood concentrations do not correlate cleanly with impairment in the way BAC correlates with alcohol impairment. Three reasons:

• Lipid solubility. THC is fat-soluble and is stored in body fat. In chronic users, the body's fat stores release THC into the bloodstream gradually, producing measurable blood concentrations long after the psychoactive effects have ended. Daily medical or recreational users can register at or above 5 ng/mL hours — sometimes days — after their last use, while behaviorally sober.
• Different absorption profiles by route. Smoked or vaporized marijuana produces peak blood concentrations within minutes of use, with peak psychoactive effects 15–30 minutes later, declining over 2–4 hours. Edibles produce delayed onset (30–90 minutes), later peak, and longer duration. That difference matters because the time between the alleged driving conduct and the chemical test — often 30 to 90 minutes — means the blood concentration at testing is often substantially different from the concentration at driving.
• No reliable behavioral correlation at fixed thresholds. Unlike alcohol, where impairment becomes measurable in driving simulators and on-road testing at predictable BAC levels, THC impairment is highly individual. The same blood concentration can produce no measurable impairment in one driver and significant impairment in another. The 5 ng/mL threshold was chosen as a policy compromise, not because the science supports a clean correlation.

All of this is admissible at trial. Defense experts on THC pharmacology — toxicologists, pharmacologists, addiction-medicine physicians — can explain to a jury why the blood number on the lab report does not capture the actual impairment level at the time of driving. Combined with body-camera footage showing competent driving, coherent speech, and intact divided-attention performance, the science becomes a powerful counter to the prosecution's reliance on the test result.

Blood-Only Testing — What That Means for the Defense

Colorado does not use breath testing for marijuana DUI. There is no THC equivalent of the Intoxilyzer 9000. Marijuana DUI chemical evidence is whole-blood testing performed by laboratory analysts on samples drawn by a certified phlebotomist. That has two practical consequences:

• More procedural attack surface. A breath test is a single device operated by the arresting officer in a controlled setting. A blood test involves a phlebotomy draw (often in a separate facility), transport to a lab, processing, storage, analyst review, and chain-of-custody documentation at every step. Each step is a potential defect point. Missing chain-of-custody entries, lapsed certifications, sample-handling errors, and lab-analyst credentialing issues recur enough that careful defense review produces real challenges in a significant minority of cases.
• Time delay between driving and testing. Smoked-THC blood concentrations decline rapidly after peak. A typical 30-to-90-minute delay between the stop and the blood draw means the lab result is measured at a substantially lower concentration than the driver had during the alleged impairment. That works in the defense's favor when the result is just above 5 ng/mL: the prosecution must argue the driver was even higher at the time of driving, while the defense can argue the result reflects a declining curve.

Drug Recognition Experts — What They Are and How They Get Challenged

When an officer suspects drug impairment rather than (or in addition to) alcohol impairment, the case is often referred to a Drug Recognition Expert (DRE) — a law-enforcement officer trained in a twelve-step evaluation protocol developed by the International Association of Chiefs of Police. The DRE protocol involves a breath-alcohol test, interview with the arresting officer, preliminary medical examination, eye examinations (pupil size, reaction to light, nystagmus), divided-attention tests, vital-sign measurements, dark-room pupil examination, muscle-tone assessment, examination for injection sites, structured interrogation, and a toxicological specimen collection. The DRE then opines on the drug category (or categories) believed to be causing impairment.

The DRE evaluation is admissible in Colorado but is subject to substantial defense challenge:

• Protocol compliance. The twelve-step protocol must be completed in sequence and in full. Skipped steps, modified steps, or omitted documentation are common and produce admissibility and weight challenges.
• Differential diagnosis. The DRE protocol requires the officer to consider and rule out medical conditions that mimic impairment indicators — diabetes, head injury, neurological conditions, prescription medications, fatigue. Failure to develop the differential is a recurring weakness.
• Certification currency. DRE certification requires periodic recertification. Lapsed credentials produce admissibility challenges.
• Inconsistency with chemical results. When the DRE concludes that the driver was under the influence of a specific drug category and the toxicology shows a different drug or no measurable drug, that inconsistency is powerful cross-examination material.

The DRE is a law-enforcement officer with specialized training, not a medical professional. A properly cross-examined DRE evaluation often becomes more useful to the defense than to the prosecution.

Variations in Colorado Marijuana DUI Cases

Edibles

Edible-cannabis cases present unique defense angles. The onset delay (30 to 90 minutes), later peak, and longer duration mean that a driver who consumed hours before the stop may have been pre-peak, peak, or post-peak at the time of driving — with significant impairment differences across each. The chemical test, drawn another 30 to 90 minutes after the stop, captures a snapshot that may or may not reflect the actual impairment level at driving. Edible-cases especially benefit from pharmacology expert testimony on the time-and-intensity curve.

Concentrates and Vaporized Cannabis

High-potency concentrates (wax, shatter, distillate) produce faster onset and higher peak blood concentrations than flower marijuana. The same dose by mass is not the same effect. That detail can cut both ways at trial — for the defense, it argues that the impairment was brief and over by driving; for the prosecution, it argues that the driver dosed heavily.

Medical Marijuana

A Colorado medical marijuana registration does not exempt the holder from the DUI-D statute. The 5 ng/mL permissive inference applies regardless of medical status. But medical marijuana use is admissible and frequently relevant. It explains chronic-user blood concentrations that may exceed the threshold without actual impairment. It contextualizes the driver's pharmacology. It can support the chronic-user defense narrative without requiring an admission of recreational use.

Combined Alcohol and Marijuana

Colorado's combined-substance DUI charge applies when both alcohol and marijuana (or other drugs) are alleged to have produced impairment. Combined cases are treated as a single DUI charge but the evidence is more complex: both a BAC result and a blood THC result are typically involved, the alcohol and marijuana pharmacology interact, and the prosecution will argue that even modest concentrations combined to produce impairment. The defense has more attack surface in combined cases — more chemical tests to challenge, more pharmacology to contest — but also a more complex evidentiary picture to manage.

How Colorado Marijuana DUI Cases Get Defended

• Attack the stop. Marijuana DUI cases proceed from a traffic stop just like alcohol cases. Pretext, prolongation, and lack of reasonable articulable suspicion challenges apply with equal force. See the Fourth Amendment traffic-stop guide.
• Attack the field investigation. Standardized Field Sobriety Tests were developed and validated for alcohol impairment, not marijuana. Their reliability as indicators of THC impairment is contested in the scientific literature. The defense can challenge SFST results in marijuana cases on grounds that do not apply in alcohol cases.
• Attack the DRE evaluation. Twelve-step protocol challenges, differential-diagnosis failures, certification lapses, and chemical-result inconsistencies.
• Attack the blood test. Chain of custody, phlebotomist certification, lab accreditation, analyst credentialing, sample-handling protocols.
• Present the pharmacology. Defense expert testimony on chronic-user pharmacokinetics, time-from-use, edibles delay, fat-store release, individual variability.
• Use the permissive inference. Argue to the jury that the prosecution must prove actual impairment, not just a number above 5. The body-camera footage often supports the argument.
• Engineer the resolution. When trial is not the right outcome, a plea structure that avoids the conviction language triggering DORA, FAA, SEAD-3, or OARC reporting may be available — especially given that DUI-D convictions affect a slightly different set of professional-licensing rules than alcohol DUI convictions.

Representative Marijuana DUI Results

• DUI Marijuana Not Guilty — Adams County, 2025. Jury verdict of not guilty on a marijuana-DUI charge with blood concentration measured at twice the per-se permissive-inference threshold.

Past results do not guarantee future outcomes; every case turns on its specific facts. See full case results.

Frequently Asked Questions

Related Colorado DUI Defense Resources

• Next Steps After a Colorado DUI Arrest
• Beating a Colorado DUI — Dismissals, Suppression & Trial
• Colorado Chemical Test Refusal Defense
• Colorado DUI & DWAI Defense — Practice Overview
• Colorado Drug Crimes Defense
• Colorado Traffic Stops and Fourth Amendment Suppression

Request a Free Colorado Marijuana DUI Consultation   Call 303-831-6111